A new review articles indicates that lower cardiovascular risk in the Latino population is clinical paradox as the population is more prone to early onset detrimental metabolic changes as compared to other ethnic groups.
A new study examines the association among statins, dementia-free and disability-free survival, and cardiovascular disease (CVD) among healthy older adults using data from the ASPREE (Aspirin in Reducing Events in the Elderly) trial.
A recently released nationwide study concluded that, when compared with development of other cardiovascular or renal diagnoses, HF development-- at any year since T2D diagnosis--was associated with the highest 5-year absolute and relative risk of death, and decrease in lifespan within 5 years.
